SE382560B - Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring - Google Patents

Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring

Info

Publication number
SE382560B
SE382560B SE7112796A SE1279671A SE382560B SE 382560 B SE382560 B SE 382560B SE 7112796 A SE7112796 A SE 7112796A SE 1279671 A SE1279671 A SE 1279671A SE 382560 B SE382560 B SE 382560B
Authority
SE
Sweden
Prior art keywords
complex
procedure
preparation
acceptable salts
salicylic acid
Prior art date
Application number
SE7112796A
Other languages
English (en)
Inventor
S Casadio
E Sclavi
R Perego
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of SE382560B publication Critical patent/SE382560B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7112796A 1970-10-09 1971-10-08 Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring SE382560B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE382560B true SE382560B (sv) 1976-02-09

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7112796A SE382560B (sv) 1970-10-09 1971-10-08 Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring

Country Status (8)

Country Link
US (1) US3853988A (sv)
CA (1) CA974883A (sv)
DE (1) DE2149699A1 (sv)
DK (1) DK129434B (sv)
ES (1) ES395533A1 (sv)
FR (1) FR2110314B1 (sv)
GB (1) GB1357737A (sv)
SE (1) SE382560B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
FR2653338B1 (fr) * 1989-10-23 1994-06-10 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
CN1146154A (zh) * 1994-03-18 1997-03-26 A·施米德特 二甲硅油在局部抗菌治疗和/或预防及治疗与幽门螺旋杆菌(Hp)有关的综合症和感染性疾病中的用途
DE4409357C2 (de) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997002019A1 (en) * 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
JP2015524395A (ja) * 2012-07-17 2015-08-24 ダウ グローバル テクノロジーズ エルエルシー 有機液体希釈剤および粘度の非常に低いセルロースエーテルを含む組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
IL26885A (en) * 1965-12-06 1970-10-30 Smith Kline French Lab Pharmaceutical silicone compositions
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
US3853988A (en) 1974-12-10
GB1357737A (en) 1974-06-26
CA974883A (en) 1975-09-23
ES395533A1 (es) 1974-10-16
DK129434B (da) 1974-10-14
DE2149699A1 (de) 1972-04-13
FR2110314B1 (sv) 1975-06-06
FR2110314A1 (sv) 1972-06-02
DK129434C (sv) 1975-03-10

Similar Documents

Publication Publication Date Title
SE393800B (sv) Forfarande for framstellning av bensoylamino-alkyl-fenoxi-alkylkarbonsyraderivat med lipidsenkande effekt
SE413578B (sv) Forfarande for framstellning av orala lekemedelspreparat med forlengda verkningstider
SE385872B (sv) Forfarande for framstellning av vissa angivna p-karbonyl - fenoxi - iso - smorsyraestrar
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE409460B (sv) Forfarande for framstellnoing av farmaceutiskt godtagbara syraadditionssalter av aminoglykosidantibiotika
NO138630C (no) Fremgangsmaate for fremstilling av 7beta-acylamido-3-metyl-ceph-3-em-4-karboksylsyre-estere
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE382560B (sv) Forfarande for framstellning av acetylsalicylsyra inklusive farmaceutiskt godtagbara salter och komplex derav innehallande farmaceutiska kompositioner med fordrojd frigoring
SE7611316L (sv) Prostansyraderivat och sett for framstellning derav
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
IL37467A0 (en) Derivatives of benzopyran-2-carboxylic acid,their preparation and pharmaceutical compositions containing them
IL40457A0 (en) New esters and salts of oburnamine type alkaloids,their preparation and pharmaceutical compositions containing them
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE420919B (sv) Forfarande for framstellning av n?722-dansyl-l-argininderivat och farmaceutiskt godtagbara syradditionssalter derav
SE406195B (sv) Forfarande for framstellning av bensocykloheptaisokinolinderivat samt syraadditionssalter derav
SE396010B (sv) Forfarande for framstellning av aktiva emnen innehallande preparat med langvarig verkan i form av tabletter, drageer eller kapslar
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE385471B (sv) Forfarande for framstellning av bensobicykloalkanaminer med analgetisk eller anti-inflammatorisk lekemedelsverkan
SE402111B (sv) Analogiforfarande for framstellning av pregnansyraderivat
SE394434B (sv) Forfarande for framstellning av vissa angivna s-triazinderivat och dess farmaceutiskt godtagbara salter
SE380517B (sv) Forfarande for framstellning av fluoren-2-ettiksyraderivat med antiinflammatorisk verkan
SE401829B (sv) Forfarande for framstellning av 5-fenyl-6,7-bensomorfanderivat och salter derav
IL30307A0 (en) Novel derivatives of acetic acid,their preparation and pharmaceutical compositions containing them